Open-Label and Single-Arm Study of MYOBLOC® in the Treatment of Troublesome Sialorrhea in Adults

NCT02610868 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

187

Enrollment

INDUSTRY

Sponsor class

Conditions

Sialorrhea

Interventions

DRUG: MYOBLOC

Sponsor

Solstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC